Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines

Biomedicine and Pharmacotherapy

Volumn 68, Issue 6, 2014, Pages 737-743

  Yalçin, Serap ^a   Erkan, Mert ^b,c   Ünsoy, Gözde ^d   Parsian, Maryam ^d   Kleeff, Jörg ^b   Gündüz, Ufuk ^d  

^a AHI EVRAN UNIVERSITY   (Turkey)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c KOÇ UNIVERSITY   (Turkey)

^d MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Gemcitabine; Nanoparticle; PAMAM dendrimer; Pancreatic cancer; Retinoic acid; Stellate cell lines

Indexed keywords

GEMCITABINE; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; POLYAMIDOAMINE; RETINOIC ACID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DENDRIMER; DEOXYCYTIDINE; MAGNETITE NANOPARTICLE; PAMAM STARBURST;

ARTICLE; CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INTERNALIZATION; MAGNETIC FIELD; MICROSCOPY; PANCREAS CANCER; PANCREATIC STELLATE CELL; ANALOGS AND DERIVATIVES; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PANCREATIC NEOPLASMS; PROCEDURES; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CELL LINE; DENDRIMERS; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETITE NANOPARTICLES; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 84908102741     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.07.003     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
2. Bilimoria K.Y., Bentrem D.J., Ko C.Y., Ritchey J., Stewart A.K., Winchester D.P., et al. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the national cancer database. Cancer 2007, 110:738-744.
3. Goldstein D., Carroll S., Apte M., Keogh G. Modern management of pancreatic carcinoma. Int Med J 2004, 34:475-481.
4. Erkan M., Hausmann S., Michalski C.W., Fingerle A.A., Dobritz M., Kleeff J., et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012, 9:454-467.
5. Erkan M., Hausmann S., Michalski C.W., Schlitter A.M., Fingerle A.A., Dobritz M., et al. How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol 2012, 3:389.
6. Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
7. Froeling F.E., Mirza T.A., Feakins R.M., Seedhar A., Elia G., Hart I.R., et al. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells. Am J Pathol 2009, 175:636-648.
8. Van de Wetering M., Cavallo R., Dooijes D., van Beest M., van Es J., Loureiro J., et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997, 88:789-799.
9. Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005, 7:469-483.
10. Apte M.V., Haber P.S., Applegate T.L., Norton I.D., McCaughan G.W., Korsten M.A., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133.
11. Love J.M., Gudas L.J. Vitamin A, differentiation and cancer. Curr Opin Cell Biol 1994, 6:825-831.
12. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996, 10:940-954.
13. Paolino D., Cosco D., Racanicchi L., Trapasso E., Celia C., Iannone M., et al. Gemcitabine-loaded PEGylated unilamellar liposomes vs GemzarW: biodistribution, pharmacokinetic features and in vivo antitumor activity. J Control Release 2010, 144:144-150.
14. Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
15. Jacobetz M.A., Chan D.S., Neesse A., Bapiro T.E., Cook N., et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2013, 62:112-120.
16. Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21:418-429.
17. Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007, 132:1447-1464.
18. Reddy L.H., Couvreur P. Novel approaches to deliver gemcitabine to cancers. Curr Pharm Des 2008, 14:1124-1137.
19. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986, 46:6387-6392.
20. Nune S.K., Gunda P., Thallapally P.K., Lin Y.Y., Forrest M.L., Berkland C.J. Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 2009, 6:1175-1194.
21. Sun C., Lee J.S.H., Zhang M.Q. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
22. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
23. Gupta A.K., Naregalkar R.R., Vaidya V.D., Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2:23-39.
24. Erkan M., Weis N., Pan Z., Schwager C., Samkharadze T., Jiang X., et al. Organ- inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 2010, 9:88.
25. Khodadust R., Unsoy G., Yalcin S., Gunduz G., Gunduz U. PAMAM dendrimer coated iron oxide nanoparticles. Synthesis and characterization of different generations. J Nanopart Res 2013, 15:1488.
26. Gao F., Pan B.F., Zheng W.M., Ao L.M., Gu H.C. Study of streptavidin coated onto PAMAM dendrimer modified magnetite nanoparticles. J Magn Mater 2005, 293:48-54.
27. Pan B.F., Gao F., Gu H.C. Dendrimer modified magnetite nanoparticles for protein immobilization. J Colloid Intef Sci 2005, 284:1-6.
28. Pan Z., Erkan M., Streit S., Friess H., Kleeff J. Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells. Int J Oncol 2009, 35:823-828.
29. Bushue N., Wan Y.J.Y. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2010, 62:1285-1298.
30. Alizadeh F., Bolhassani A., Khavari A., Bathaie S.Z., Naji T., Bidgoli S.A. Retinoids and their biological effects againstcancer. Int. Immunopharmacol. 2013, 18:43-49.
31. Pettersson F., Colston K.W., Dalgleish A.G. Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells. Pancreas 2001, 23:273-279.
32. McCarroll J.A., Phillips P.A., Santucci N., Pirola R.C., Wilson J.S., Apte M.V. Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut 2006, 55:79-89.
33. Froeling F.E., Feig C., Chelala C., Dobson R., Mein C.E., Tuveson D.A., et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. Gastroenterology 2011, 141:1486-1497.
34. Noble S., Goa K.L. Gemcitabine: a review of its pharmacology and clinical potential in non-small lung cancer and pancreatic cancer. Drugs 1997, 54:447-472.
35. Plunkett W., Huang P., Xu Y.Z., Heinemann V., Grunewald R., Gandhi V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 1995, 22:3-10.
36. Huang P., Plunkett W. Induction of apoptosis by gemcitabine. Semin Oncol 1995, 22:19-25.
37. Plunkett W., Huang P., Searcy C.E., Gandhi V. Gemcitabine: preclinical pharmacology and mechanisms of action. Semin Oncol 1996, 23:3-15.
38. Arya G., Vandana M., Acharya S., Sahoo S.K. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine 2011, 7:859-870.
39. Michael A., Hill M., Maraveyas A., Dalgleish A., Lofts F. 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastaticpancreatic cancer-report of a pilot phase II study. Clin Oncol 2007, 19:150-153.